Insecticides (india) Limited · NSE:INSECTICID
Insecticides (india) — Q1 FY2024 Earnings Presentation
7 slides from Insecticides (india)'s earnings presentation, Aug 10, 2023
Slide 1: Earning Update for Q1 FY2024 - Stock Exchange Cover Letter
Ref: IIL/SE/2023/1008/2 Dated: August 10, 2023 The Manager Listing Compliance Department Listing Compliance Department BSE Limited National Stock Exchange of India Limited (Through BSE Listing Centre) (Through NEAPS) Scrip Code: 532851 Symbol: INSECTICID Dear Sir/Madam, Sub: Earning Update for Q1 FY
Slide 2: Q1 FY24 – Earnings Update
CIN: L65991DL1996PLC083909 Registered Office: 401-402, Lusa Tower, Azadpur Commercial Complex, Delhi – 110033 Q1 FY24 – Earnings Update Revenue from Operations reported at INR 6,399.53 Mn in Q1 FY24 EBITDA stands at INR 456.48 Mn in Q1 FY24 PAT at INR 291.42 Mn in Q1 FY24 Delhi, 10th August 2023: In
Slide 3: Revenue Mix and Gross Revenue from New Product Launches
Maharatna vs Others Region Mix 100% 100% 22% 24% 80% 39% 80% 45% 60% 60% 35% 32% 40% 40% 7% 61% 22% 55% 20% 20% 36% 22% 0% 0% Q1 FY24 Q1 FY23 Q1 FY24 Q1 FY23 Maharatna Sales Other Branded Sales North East West South Product Freshness Index: IIL through its extensive R&D capabilities is committed to
Slide 4: Quarterly Comparison (Rs in Millions)
Financial Snapshot: IIL continuing on a revenue growth path despite challenges in the industry Quarterly Comparison (Rs in Millions) 7000.00 12.00% ₹ 6,399.53 10.43% 6000.00 ₹ 5,606.90 10.00% 5000.00 6.83% 8.00% 4000.00 7.13% 6.00% 3000.00 4.55% 4.00% 2000.00 1000.00 2.00% ₹ 584.53 ₹ 383.09 ₹ 456.48
Slide 5: Consolidated Financial Performance Comparison – Q1 FY24 v/s Q1 FY23
Consolidated Financial Performance Comparison – Q1 FY24 v/s Q1 FY23 • Revenue from operations increased by 14.14% to ₹ 6,399.53 Mn in Q1 FY24 from ₹ 5,606.90 Mn in Q1 FY23 on account of favourable monsoon conditions and increasing share of Focused Maharatna products like Hachiman, Shinwa and Torry a
Slide 6: Management expects increase in topline by 10%-12% in FY24
Looking ahead, we anticipate a sustainable growth trajectory in the market driven by favourable monsoon conditions, an array of Maharatna product launches and stabilisation of prices. We recently launched promising products in the form of Mission granule and Mission liquid, both of which have receiv
Slide 7: Disclaimer and Contact Details
Disclaimer: Certain statements in this document may be forward looking statements. Such forward- looking statements are subject to certain risks and uncertainties like government actions, local political or economic developments, technological risks, and many other factors that could cause our actua
Insecticides (India) — Q1 FY2024 Earnings Presentation on 6ix